NCT07555756Not yet recruiting
An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models
Source: ClinicalTrials.gov · Last updated 29 Apr 2026
Brief summary (registry, in English)
This study evaluates our team's urology-specific AI (UroMed AI Doctor) for its safety, professionalism, knowledge and Q\&A ability, and tests its effectiveness against traditional manual urology care, to confirm if it can be a safe auxiliary tool and improve patients' preoperative experience. Before the study, we will test the AI with urology questions, compare it to international AI models (DeepSeek, ChatGPT, Google Gemini), and have two senior chief physicians evaluate it. In the clinical trial, patients at The First Affiliated Hospital of Guangxi Medical University will be randomly split into two groups: AI-assisted care or traditional care by a specialist. Two senior specialists will evaluate both groups blindly; each group will get preoperative education (AI or physician), with anxiety and satisfaction surveyed. Subsequently, a multi-center validation will be conducted with 11 domestic and international hospitals.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 1080 (estimated)
- First submitted
- 21 Apr 2026
- Start date
- 1 May 2026
- Primary completion date
- 30 Apr 2029
- Lead sponsor
- First Affiliated Hospital of Guangxi Medical University
- Diseases
- Bladder cancer
- NCT number
- NCT07555756
What you commit to
- Study type: Interventional
- Planned participants: 1080
- From 1 May 2026 to the primary completion date, 30 Apr 2029
- 5 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Suffers from psychiatric disorders. Refuses to participate in medical activities involving the use of artificial intelligence systems.
- Unable to engage in effective communication with the research team. Has multiple underlying diseases with unstable clinical conditions.
Who the study is looking for
- Diagnosed with kidney stones, benign prostatic hyperplasia, or bladder cancer in line with the Chinese Guidelines for the Diagnosis and Treatment of Urological and Andrological Diseases (2022 Edition) and requiring hospitalization for surgery.
- Aged 18 to 60 years with good communication skills. Voluntarily agrees to participate in the clinical study and has signed the informed consent form.
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Guangxi Medical University Coordinator of this site? Confirm its status | Nanning | China | Unknown status |
| Viet Duc University Hospital Coordinator of this site? Confirm its status | Hanoi | Vietnam | Unknown status |
| Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City Coordinator of this site? Confirm its status | Ho Chi Minh City | Vietnam | Unknown status |
| Hue Central Hospital Coordinator of this site? Confirm its status | Huế | Vietnam | Unknown status |
| Binh Duong General Hospital Coordinator of this site? Confirm its status | Thu Dau Mot | Vietnam | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.